申请人:Ciba-Geigy Corporation
公开号:US04444775A1
公开(公告)日:1984-04-24
Disclosed are e.g. novel 5-(carboxyalkyl)imidazo[1,5-a]pyridines, their derivatives and methods of synthesis. Said compounds are useful as selective thromboxane synthetase inhibitors for the treatment of diseases such as cerebral ischaemia, shock, thrombosis and ischaemic heart disease.
公开了例如新颖的5-(羧基烷基)咪唑[1,5-a]吡啶类化合物,它们的衍生物以及合成方法。所述化合物可用作选择性血栓素合成酶抑制剂,用于治疗脑缺血、休克、血栓形成和缺血性心脏病等疾病。